170 related articles for article (PubMed ID: 37726802)
1. Comparison of Huntington's disease phenotype progression in male and female heterozygous FDNQ175 mice.
Li SH; Colson TL; Chen J; Abd-Elrahman KS; Ferguson SSG
Mol Brain; 2023 Sep; 16(1):67. PubMed ID: 37726802
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive behavioral and molecular characterization of a new knock-in mouse model of Huntington's disease: zQ175.
Menalled LB; Kudwa AE; Miller S; Fitzpatrick J; Watson-Johnson J; Keating N; Ruiz M; Mushlin R; Alosio W; McConnell K; Connor D; Murphy C; Oakeshott S; Kwan M; Beltran J; Ghavami A; Brunner D; Park LC; Ramboz S; Howland D
PLoS One; 2012; 7(12):e49838. PubMed ID: 23284626
[TBL] [Abstract][Full Text] [Related]
3. Metabotropic Glutamate Receptor 2/3 Activation Improves Motor Performance and Reduces Pathology in Heterozygous zQ175 Huntington Disease Mice.
Li SH; Colson TL; Abd-Elrahman KS; Ferguson SSG
J Pharmacol Exp Ther; 2021 Oct; 379(1):74-84. PubMed ID: 34330748
[TBL] [Abstract][Full Text] [Related]
4. VGLUT3 Deletion Rescues Motor Deficits and Neuronal Loss in the zQ175 Mouse Model of Huntington's Disease.
Ibrahim KS; El Mestikawy S; Abd-Elrahman KS; Ferguson SSG
J Neurosci; 2023 Jun; 43(23):4365-4377. PubMed ID: 37055181
[TBL] [Abstract][Full Text] [Related]
5. Novel BAC Mouse Model of Huntington's Disease with 225 CAG Repeats Exhibits an Early Widespread and Stable Degenerative Phenotype.
Wegrzynowicz M; Bichell TJ; Soares BD; Loth MK; McGlothan JS; Mori S; Alikhan FS; Hua K; Coughlin JM; Holt HK; Jetter CS; Pomper MG; Osmand AP; Guilarte TR; Bowman AB
J Huntingtons Dis; 2015; 4(1):17-36. PubMed ID: 26333255
[TBL] [Abstract][Full Text] [Related]
6. Quantitative Electroencephalographic Analysis Provides an Early-Stage Indicator of Disease Onset and Progression in the zQ175 Knock-In Mouse Model of Huntington's Disease.
Fisher SP; Schwartz MD; Wurts-Black S; Thomas AM; Chen TM; Miller MA; Palmerston JB; Kilduff TS; Morairty SR
Sleep; 2016 Feb; 39(2):379-91. PubMed ID: 26446107
[TBL] [Abstract][Full Text] [Related]
7. Metabotropic Glutamate Receptor 5 Antagonism Reduces Pathology and Differentially Improves Symptoms in Male and Female Heterozygous zQ175 Huntington's Mice.
Li SH; Colson TL; Abd-Elrahman KS; Ferguson SSG
Front Mol Neurosci; 2022; 15():801757. PubMed ID: 35185467
[TBL] [Abstract][Full Text] [Related]
8. Characterization of neurophysiological and behavioral changes, MRI brain volumetry and 1H MRS in zQ175 knock-in mouse model of Huntington's disease.
Heikkinen T; Lehtimäki K; Vartiainen N; Puoliväli J; Hendricks SJ; Glaser JR; Bradaia A; Wadel K; Touller C; Kontkanen O; Yrjänheikki JM; Buisson B; Howland D; Beaumont V; Munoz-Sanjuan I; Park LC
PLoS One; 2012; 7(12):e50717. PubMed ID: 23284644
[TBL] [Abstract][Full Text] [Related]
9. Cognitive deficits in transgenic and knock-in HTT mice parallel those in Huntington's disease.
Farrar AM; Murphy CA; Paterson NE; Oakeshott S; He D; Alosio W; McConnell K; Menalled LB; Ramboz S; Park LC; Howland D; Brunner D
J Huntingtons Dis; 2014; 3(2):145-58. PubMed ID: 25062858
[TBL] [Abstract][Full Text] [Related]
10. A Longitudinal Motor Characterisation of the HdhQ111 Mouse Model of Huntington's Disease.
Yhnell E; Dunnett SB; Brooks SP
J Huntingtons Dis; 2016 May; 5(2):149-61. PubMed ID: 27258586
[TBL] [Abstract][Full Text] [Related]
11. Compromised Dopaminergic Encoding of Reward Accompanying Suppressed Willingness to Overcome High Effort Costs Is a Prominent Prodromal Characteristic of the Q175 Mouse Model of Huntington's Disease.
Covey DP; Dantrassy HM; Zlebnik NE; Gildish I; Cheer JF
J Neurosci; 2016 May; 36(18):4993-5002. PubMed ID: 27147652
[TBL] [Abstract][Full Text] [Related]
12. An enhanced Q175 knock-in mouse model of Huntington disease with higher mutant huntingtin levels and accelerated disease phenotypes.
Southwell AL; Smith-Dijak A; Kay C; Sepers M; Villanueva EB; Parsons MP; Xie Y; Anderson L; Felczak B; Waltl S; Ko S; Cheung D; Dal Cengio L; Slama R; Petoukhov E; Raymond LA; Hayden MR
Hum Mol Genet; 2016 Sep; 25(17):3654-3675. PubMed ID: 27378694
[TBL] [Abstract][Full Text] [Related]
13. Characterization of Behavioral, Neuropathological, Brain Metabolic and Key Molecular Changes in zQ175 Knock-In Mouse Model of Huntington's Disease.
Peng Q; Wu B; Jiang M; Jin J; Hou Z; Zheng J; Zhang J; Duan W
PLoS One; 2016; 11(2):e0148839. PubMed ID: 26859386
[TBL] [Abstract][Full Text] [Related]
14. Pharmacogenetic modulation of STEP improves motor and cognitive function in a mouse model of Huntington's disease.
García-Forn M; Martínez-Torres S; García-Díaz Barriga G; Alberch J; Milà M; Azkona G; Pérez-Navarro E
Neurobiol Dis; 2018 Dec; 120():88-97. PubMed ID: 30176350
[TBL] [Abstract][Full Text] [Related]
15. Temporal Phenotypic Changes in Huntington's Disease Models for Preclinical Studies.
St-Cyr S; Smith AR; Davidson BL
J Huntingtons Dis; 2022; 11(1):35-57. PubMed ID: 35213386
[TBL] [Abstract][Full Text] [Related]
16. Alterations of striatal indirect pathway neurons precede motor deficits in two mouse models of Huntington's disease.
Sebastianutto I; Cenci MA; Fieblinger T
Neurobiol Dis; 2017 Sep; 105():117-131. PubMed ID: 28578004
[TBL] [Abstract][Full Text] [Related]
17. Formation of polyglutamine inclusions in a wide range of non-CNS tissues in the HdhQ150 knock-in mouse model of Huntington's disease.
Moffitt H; McPhail GD; Woodman B; Hobbs C; Bates GP
PLoS One; 2009 Nov; 4(11):e8025. PubMed ID: 19956633
[TBL] [Abstract][Full Text] [Related]
18. A broad phenotypic screen identifies novel phenotypes driven by a single mutant allele in Huntington's disease CAG knock-in mice.
Hölter SM; Stromberg M; Kovalenko M; Garrett L; Glasl L; Lopez E; Guide J; Götz A; Hans W; Becker L; Rathkolb B; Rozman J; Schrewed A; Klingenspor M; Klopstock T; Schulz H; Wolf E; Wursta W; Gillis T; Wakimoto H; Seidman J; MacDonald ME; Cotman S; Gailus-Durner V; Fuchs H; de Angelis MH; Lee JM; Wheeler VC
PLoS One; 2013; 8(11):e80923. PubMed ID: 24278347
[TBL] [Abstract][Full Text] [Related]
19. Phenotype onset in Huntington's disease knock-in mice is correlated with the incomplete splicing of the mutant huntingtin gene.
Franich NR; Hickey MA; Zhu C; Osborne GF; Ali N; Chu T; Bove NH; Lemesre V; Lerner RP; Zeitlin SO; Howland D; Neueder A; Landles C; Bates GP; Chesselet MF
J Neurosci Res; 2019 Dec; 97(12):1590-1605. PubMed ID: 31282030
[TBL] [Abstract][Full Text] [Related]
20. A series of N-terminal epitope tagged Hdh knock-in alleles expressing normal and mutant huntingtin: their application to understanding the effect of increasing the length of normal Huntingtin's polyglutamine stretch on CAG140 mouse model pathogenesis.
Zheng S; Ghitani N; Blackburn JS; Liu JP; Zeitlin SO
Mol Brain; 2012 Aug; 5():28. PubMed ID: 22892315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
